United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (united states - pimozide - tablet - 1mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

janssen pharmaceutica n.v, belgium - pimozide - tablet - 4 mg

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Singapore - English - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - escitalopram - tablet, film coated - 10 mg - escitalopram 10 mg

Singapore - English - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - escitalopram - tablet, film coated - 15 mg - escitalopram 15 mg

Singapore - English - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - escitalopram - tablet, film coated - 20 mg - escitalopram 20 mg

Singapore - English - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - escitalopram - tablet, film coated - 5 mg - escitalopram 5 mg

Malta - English - Medicines Authority

actavis h.f. - citalopram hydrobromide 20 mg - film-coated tablet

United States - English - NLM (National Library of Medicine)

edgemont pharmaceuticals, llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 60 mg - fluoxetine is indicated for the treatment of: the use of maois intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine is contraindicated because of an increased risk of serotonin syndrome. the use of fluoxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.6) and warnings and precautions (5.2)] . starting fluoxetine in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see dosage and administration ( 2.7 ) and warnings and precautions (5.2 )] . the use of fluoxetine is contraindicated with the following: pimozide and thioridazine prolong the qt interval. fluoxetine can increase the levels of pimozide and thioridazine through inhibition of cyp2d6. fluoxetine can also prolong the qt interval. pregnancy category c —fluoxetine should be used during pregnancy

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - fluvoxamine maleate (unii: 5lgn83g74v) (fluvoxamine - unii:o4l1xpo44w) - fluvoxamine maleate 50 mg - fluvoxamine maleate tablets usp are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd), as defined in dsm-iii-r or dsm-iv. the obsessions or compulsions cause marked distress, are time-consuming or significantly interfere with social or occupational functioning. obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. the efficacy of fluvoxamine maleate tablets usp was established in three trials in outpatients with ocd: two 10-week trials in adults, one 10-week trial in pediatric patients (ages 8 to 17) (see 14 clinical studies ). co-administration of tizanidine, thioridazine, alosetron or pimozide with fluvoxamine maleate is contraindicated (see warnings and precautions, 5.4 potential thioridazine interaction, 5.5 potential tizan